CMS
delays controversial best price requirement for drugmakers
|
|
CMS delayed the
Medicaid drug rebate program requirements until July 2022. Drugmakers sued
the federal government over them last week. |
CMS
delays controversial best price requirement for drugmakers
|
|
CMS delayed the
Medicaid drug rebate program requirements until July 2022. Drugmakers sued
the federal government over them last week. |
No comments:
Post a Comment